The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
A Common Pharmacophore for a Diverse Set of Colchicine Site Inhibitors Using a Structure-Based Approach
Abstract
Modulating the structure and function of tubulin and microtubules is an important route to anticancer therapeutics, and therefore, small molecules that bind to tubulin and cause mitotic arrest are of immense interest. A large number of synthetic and natural compounds with diverse structures have been shown to bind at the colchicine site, one of the major binding sites on tubulin, and inhibit tubulin assembly. Using the recently determined X-ray structure of the tubulin:colchicinoid complex as the template, we employed docking studies to determine the binding modes of a set of structurally diverse colchicine site inhibitors. These binding models were subsequently used to construct a comprehensive, structure-based pharmacophore that in combination with molecular dynamics simulations confirms and extends our understanding of binding interactions at the colchicine site.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
Ravelli, R. B. G., Gigant, B., Curmi, P. A., Jourdain, I., Lachkar, S., Sobel, A., & Knossow, M. (2004) · Nature · doi:10.1038/nature02393 · Cited by 1,630
Environment and exposure to solvent of protein atoms. Lysozyme and insulin
Shrake, A., & Rupley, J. A. (1973) · Journal of Molecular Biology · doi:10.1016/0022-2836(73)90011-9 · Cited by 1,375
Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle
Jordan, A., Hadfield, J. A., Lawrence, N. J., & McGown, A. T. (1998) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u · Cited by 673
Functional group contributions to drug-receptor interactions
Andrews, P. R., Craik, D. J., & Martin, J. L. (1984) · Journal of Medicinal Chemistry · doi:10.1021/jm00378a021 · Cited by 535
HINT: A new method of empirical hydrophobic field calculation for CoMFA
Kellogg, G. E., Semus, S. F., & Abraham, D. J. (1991) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00135313 · Cited by 333
Arylthioindoles, Potent Inhibitors of Tubulin Polymerization
De Martino, G., La Regina, G., Coluccia, A., Edler, M. C., Barbera, M. C., Brancale, A., Wilcox, E., Hamel, E., Artico, M., & Silvestri, R. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049360d · Cited by 294
Self-citationVerdier-Pinard, P., Lai, J.-Y., Yoo, H.-D., Yu, J., Marquez, B., Nagle, D. G., Nambu, M., White, J. D., Falck, J. R., Gerwick, W. H., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.53.1.62 · Cited by 282
Self-citationCragg, G. M., & Newman, D. J. (2004) · Journal of Natural Products · doi:10.1021/np030420c · Cited by 210
Tubulin structure: insights into microtubule properties and functions
Downing, K. H., & Nogales, E. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80099-7 · Cited by 201
Sackett, D. L. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90044-e · Cited by 177
Antineoplastic Agents. 465. Structural Modification of Resveratrol: Sodium Resverastatin Phosphate
Pettit, G. R., Grealish, M. P., Jung, M. K., Hamel, E., Pettit, R. K., Chapuis, J.-C., & Schmidt, J. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010119y · Cited by 172
Self-citationCushman, M., He, H.-M., Katzenellenbogen, J. A., Varma, R. K., Hamel, E., Lin, C. M., Ram, S., & Sachdeva, Y. P. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9700833 · Cited by 93
Self-citationWipf, P., Reeves, J. T., Balachandran, R., Giuliano, K. A., Hamel, E., & Day, B. W. (2000) · Journal of the American Chemical Society · doi:10.1021/ja002213u · Cited by 92
Self-citationWipf, P., Reeves, J. T., Balachandran, R., & Day, B. W. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0105171 · Cited by 87
Self-citationNew insights into microtubule structure and function from the atomic model of tubulin
Downing, K. H., & Nogales, E. (1998) · European Biophysics Journal · doi:10.1007/s002490050153 · Cited by 67
A Steroid Derivative with Paclitaxel-Like Effects on Tubulin Polymerization
Verdier‐Pinard, P., Wang, Z., Mohanakrishnan, A. K., Cushman, M., & Hamel, E. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26423-3 · Cited by 58
Self-citationEdsall, A. B., Mohanakrishnan, A. K., Yang, D., Fanwick, P. E., Hamel, E., Hanson, A. D., Agoston, G. E., & Cushman, M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049647a · Cited by 54
Self-citationCushman, M., Mohanakrishnan, A. K., Hollingshead, M. G., & Hamel, E. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020218r · Cited by 42
Self-citationVerdier‐Pinard, P., Sitachitta, N., Rossi, J. V., Sackett, D. L., Gerwick, W. H., & Hamel, E. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1363 · Cited by 32
Self-citation
Cited by
An overview of tubulin inhibitors that interact with the colchicine binding site
Lu, Y., Chen, J., Xiao, M., Li, W., & Miller, D. D. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0828-z · Cited by 709
Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulin
Bhattacharyya, B., Panda, D., Gupta, S., & Banerjee, M. (2008) · Medicinal Research Reviews · doi:10.1002/med.20097 · Cited by 499
Recent developments in tubulin polymerization inhibitors: An overview
Kaur, R., Kaur, G., Gill, R. K., Soni, R., & Bariwal, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.051 · Cited by 344
Messaoudi, S., Tréguier, B., Hamze, A., Provot, O., Peyrat, J.-F., De Losada, J. R., Liu, J.-M., Bignon, J., Wdzieczak-Bakala, J., Thoret, S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900321u · Cited by 287
Metadata
- Authors
- Nguyen, T. L., McGrath, C., Hermone, A. R., Burnett, J. C., Zaharevitz, D. W., Day, B. W., Wipf, P., Hamel, E., & Gussio, R.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2005-08-23
- Volume
- 48
- Issue
- 19
- Pages
- 6107-6116
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1966813923
- Cited by
- 286
- References
- 19
- FWCI
- 12.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.